Compounds and methods for diagnosis of tuberculosis

Details Compounds and methods for diagnosis of tuberculosis Compounds and methods for diagnosis of tuberculosis

2005-09-27

2005-09-27

Swartz, Rodney P (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S130100, C424S139100, C424S150100, C424S184100, C424S185100, C424S234100, C435S006120, C530S333000, C530S350000, C536S023700

Reexamination Certificate

active

06949246

ABSTRACT:
Compounds and methods for diagnosing tuberculosis are disclosed. The compounds provided include polypeptides that contain at least one antigenic portion of one or moreM. tuberculosisproteins, and DNA sequences encoding such polypeptides. Diagnostic kits containing such polypeptides or DNA sequences and a suitable detection reagent may be used for the detection ofM. tuberculosisinfection in patients and biological samples. Antibodies directed against such polypeptides are also provided.

REFERENCES:
patent: 3943119 (1976-03-01), Tsumita et al.
patent: 5108745 (1992-04-01), Horwitz
patent: 419 355 (1991-03-01), None
patent: 519 218 (1992-12-01), None
patent: 2 244 539 (1975-05-01), None
patent: 2 265 402 (1975-11-01), None
patent: WO 88/05823 (1988-08-01), None
patent: WO 91/04272 (1991-04-01), None
patent: WO 91/14448 (1991-10-01), None
patent: WO 92/04049 (1992-03-01), None
patent: WO 92/14823 (1992-09-01), None
patent: WO 92/21758 (1992-12-01), None
patent: WO 94/00493 (1994-01-01), None
patent: WO 95/01440 (1995-01-01), None
patent: WO 95/01441 (1995-01-01), None
patent: WO 95/14713 (1995-06-01), None
patent: WO 95/31216 (1995-11-01), None
patent: WO 96/15241 (1996-05-01), None
patent: WO 96/23885 (1996-08-01), None
patent: WO 97/09428 (1997-03-01), None
patent: WO 97/09429 (1997-03-01), None
Andersen and Hansen, “Structure and Mapping of Antigenic Domains of Protein Antigen b, a 38,000-Molecular-Weight Protein ofMycobacterium tuberculosis,” Infection and Immunity37(8):2481-2488, 1989.
Andersen et al., “Identification of Immunodominant Antigens during Infection withMycobacterium tuberculosis,” Scand. J. Immunol. 36:823-831, 1992.
Andersen, P., “Effective Vaccination of Mice againstMycobacterium tuberculosisInfection with a Soluble Mixture of Secreted Mycobacterial Proteins,”Infection and Immunity62(6):2536-2544, 1994.
Ausebel et al., “Isolation of Proteins for Microsequence Analysis,” in Current Protocols in Molecular Biology, Wiley & Sons, New York, 1993, pp. 10.19.1-10.19.12.
Barnes et al., “Immunoreactivity of a 10-kDa Antigen ofMycobacterium tuberculosis,” The Journal of Immunology148(6):1835-1840, 1992.
Boesen et al., “Human T-Cell Responses to Secreted Antigen Fractions ofMycobacterium tuberculosis,” Infection and Immunity63(4):1491-1497, 1995.
Borremans et al., “Cloning, Sequencing Determination, and Expression of a 32-Kilodalton-Protein Gene ofMycobacterium tuberculosis,” Infection and Immunity57(10):3123-3130, 1989.
Content et al., “The Genes Coding for the Antigen 85 Complexes ofMycobacterium tuberculosisandMycobacterium bovisBCG Are Members of a Gene Family: Cloning, Sequence Determination, and Genomic Orginization of the Gene Coding for Antigen 85-C ofM. tuberculosis,” Infection and Immunity59:3205-3212, 1991.
Horowitz et al., “Protective immunity against tuberculosis induced by vaccination with major extracellular proteins ofMycobacterium tuberculosis,” Proc. Natl. Acad. Sci. USA92:1530-1534, 1995.
Lowrie et al., “Towards a DNA vaccine against tuberculosis,”Vaccine12(16):1537-1540, 1994.
Matsumoto et al., “Cloning and Sequencing of a Unique Antigen MPT70 fromMycobacterium tuberculosisH37Rv and Expression in BCG UsingE. coli-Mycobacteria Shuttle Vector,”Scand. J. Immunol.41:281-287, 1995.
Nagai et al., “Isolation and Partial Characterization of Major Protein Antigens in the Culture Fluid ofMycobacterium tuberculosis,” Infection and Immunity59(1):372-382, 1991.
Oettinger and Andersen, “Cloning and B-Cell-Epitope Mapping of MPT64 fromMycobacterium tuberculosisH37Rv,”Infection and Immunity62(5):2058-2064, 1994.
Pal and Horwitz, “Immunization with Extracellular Proteins ofMycobacterium tuberculosisInduces Cell-Mediated Immune Responses and Substantial Protective Immunity in a Guinea Pig Model of Pulmonary Tuberculosis,”Infection and Immunity60(11):4781-4792, 1992.
Romain et al., “Isolation of a proline-rich mycobacterial protein eliciting delayed-type hypersensitivity reactions only in a guinea pigs immunized with living mycobacteria,”Proc. Natl. Acad. Sci. USA90:5322-5326, 1993.
Romain et al., “Preparation of Tuberculin Antigen L,”Ann. Inst. Pasteur/Microbiol. 136B:235-248, 1985.
Wallis et al., “Identification of Antigens ofMycobacterium tuberculosisUsing Human Monoclonal Antibodies,”J. Clin. Invest. 84:214-219, 1989.
Wiker and Harboe, “The Antigen 85 Complex: a Major Secretion Product ofMycobacterium tuberculosis,” Microbiological Reviews56(4):648-661, 1992.
Yamaguchi et al., “Cloning and Characterization of the Gene for Immunogenic Protein MPB64 ofMycobacterium bovisBCG,”Infection and Immunity57(1):283-288, 1989.
Young et al., “Screening of a Recombinant Mycobacterial DNA Library with Polyclonal Antiserum and Molecular Weight Analysis of Expressed Antigens,”Infection and Immunity55(6):1421-1425, 1987.

Affiliated with

Also associated with

Rating

Compounds and methods for diagnosis of tuberculosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and methods for diagnosis of tuberculosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for diagnosis of tuberculosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3417983